1. Home
  2. COGT vs WEST Comparison

COGT vs WEST Comparison

Compare COGT & WEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • WEST
  • Stock Information
  • Founded
  • COGT 2014
  • WEST 2009
  • Country
  • COGT United States
  • WEST United States
  • Employees
  • COGT N/A
  • WEST N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • WEST Beverages (Production/Distribution)
  • Sector
  • COGT Health Care
  • WEST Consumer Staples
  • Exchange
  • COGT Nasdaq
  • WEST Nasdaq
  • Market Cap
  • COGT 545.3M
  • WEST 537.5M
  • IPO Year
  • COGT 2018
  • WEST N/A
  • Fundamental
  • Price
  • COGT $4.81
  • WEST $7.26
  • Analyst Decision
  • COGT Buy
  • WEST Strong Buy
  • Analyst Count
  • COGT 7
  • WEST 5
  • Target Price
  • COGT $14.00
  • WEST $10.60
  • AVG Volume (30 Days)
  • COGT 1.3M
  • WEST 240.9K
  • Earning Date
  • COGT 05-06-2025
  • WEST 05-08-2025
  • Dividend Yield
  • COGT N/A
  • WEST N/A
  • EPS Growth
  • COGT N/A
  • WEST N/A
  • EPS
  • COGT N/A
  • WEST N/A
  • Revenue
  • COGT N/A
  • WEST $872,022,000.00
  • Revenue This Year
  • COGT N/A
  • WEST $23.19
  • Revenue Next Year
  • COGT N/A
  • WEST $14.31
  • P/E Ratio
  • COGT N/A
  • WEST N/A
  • Revenue Growth
  • COGT N/A
  • WEST 2.38
  • 52 Week Low
  • COGT $3.72
  • WEST $5.28
  • 52 Week High
  • COGT $12.61
  • WEST $10.99
  • Technical
  • Relative Strength Index (RSI)
  • COGT 44.64
  • WEST 68.73
  • Support Level
  • COGT $4.55
  • WEST $5.90
  • Resistance Level
  • COGT $5.89
  • WEST $6.41
  • Average True Range (ATR)
  • COGT 0.38
  • WEST 0.39
  • MACD
  • COGT 0.09
  • WEST 0.14
  • Stochastic Oscillator
  • COGT 34.55
  • WEST 80.01

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

Share on Social Networks: